Interleukin-22 and Interleukin-18 as Potential Blood Biomarkers in Dupilumab-Treated Atopic Dermatitis.

Fukushima-Nomura A, Kawasaki H, Hasegawa T, Yanagisawa E, Tanese K, Yanagida N, Obata S, Yashiro K, Ito Y, Koseki H, Amagai M

Open source

DOI: 10.1111/all.70248
Published: 2026 Jul
Container: Allergy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/all.70248,
  title = {Interleukin-22 and Interleukin-18 as Potential Blood Biomarkers in Dupilumab-Treated Atopic Dermatitis.},
  author = {Fukushima-Nomura A and Kawasaki H and Hasegawa T and Yanagisawa E and Tanese K and Yanagida N and Obata S and Yashiro K and Ito Y and Koseki H and Amagai M},
  year = {2026},
  journal = {Allergy},
  doi = {10.1111/all.70248},
  url = {https://doi.org/10.1111/all.70248}
}

RIS

TY  - JOUR
TI  - Interleukin-22 and Interleukin-18 as Potential Blood Biomarkers in Dupilumab-Treated Atopic Dermatitis.
AU  - Fukushima-Nomura A
AU  - Kawasaki H
AU  - Hasegawa T
AU  - Yanagisawa E
AU  - Tanese K
AU  - Yanagida N
AU  - Obata S
AU  - Yashiro K
AU  - Ito Y
AU  - Koseki H
AU  - Amagai M
PY  - 2026
JO  - Allergy
DO  - 10.1111/all.70248
UR  - https://doi.org/10.1111/all.70248
ER  -

APA

A, F., H, K., T, H., E, Y., K, T., N, Y., S, O., K, Y., Y, I., H, K., & M, A. (2026). Interleukin-22 and Interleukin-18 as Potential Blood Biomarkers in Dupilumab-Treated Atopic Dermatitis.. Allergy. https://doi.org/10.1111/all.70248

Source records

pubmed · retrieved 2026-09-26T21:28:22.087Z